Cargando…

AAV gene therapy vectors in the TMJ

OBJECTIVES: The goal of this project was to evaluate the use of two adeno‐associated viral vector serotypes, adeno‐associated viral vectors (AAV)‐2 and AAV‐6, approved for and used for gene therapy in humans, for the delivery of therapeutic genes to the temporomandibular joint (TMJ) and the attendan...

Descripción completa

Detalles Bibliográficos
Autores principales:	Brouxhon, Sabine M., O'Banion, Michael Kerry, Kyrkanides, Stephanos
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2022
Materias:	Original Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9760151/ https://www.ncbi.nlm.nih.gov/pubmed/35871478 http://dx.doi.org/10.1002/cre2.636

Ejemplares similares

Calcitonin gene‐related peptide: An intra‐articular therapeutic target for TMJ disorders
por: Brouxhon, Sabine M., et al.
Publicado: (2022)

Conditional expression of human β-hexosaminidase in the neurons of Sandhoff disease rescues mice from neurodegeneration but not neuroinflammation
por: Kyrkanides, Stephanos, et al.
Publicado: (2012)

Reprogramming oral epithelial keratinocytes into a pluripotent phenotype for tissue regeneration
por: Bazina, Fayrouz, et al.
Publicado: (2021)

Osteoarthritis accelerates and exacerbates Alzheimer's disease pathology in mice
por: Kyrkanides, Stephanos, et al.
Publicado: (2011)

Partial epithelial–mesenchymal transition during enamel development
por: Bazina, Fayrouz, et al.
Publicado: (2022)

Conditional ablation of E‐cadherin in the oral epithelium progeny results in tooth anomalies
por: Kyrkanides, Stephanos, et al.
Publicado: (2022)

Inconsistent Effects of Glatiramer Acetate Treatment in the 5xFAD Mouse Model of Alzheimer’s Disease
por: Karaahmet, Berke, et al.
Publicado: (2023)

The role of interleukin-1 in neuroinflammation and Alzheimer disease: an evolving perspective
por: Shaftel, Solomon S, et al.
Publicado: (2008)

Does an old dog need new tricks? Advancement of limb salvage in treating chronic limb threatening ischemia
por: O'Banion, Leigh Ann
Publicado: (2023)

Neuroinflammation and M2 microglia: the good, the bad, and the inflamed
por: Cherry, Jonathan D, et al.
Publicado: (2014)

Arginase 1+ microglia reduce Aβ plaque deposition during IL-1β-dependent neuroinflammation
por: Cherry, Jonathan D., et al.
Publicado: (2015)

Are “Resting” Microglia More “M2”?
por: Cherry, Jonathan D., et al.
Publicado: (2014)

Evaluation of TMJ sound on the subject with TMJ disorder by Joint Vibration Analysis
por: Hwang, In-Taek, et al.
Publicado: (2009)

Syngeneic AAV Pseudo-particles Potentiate Gene Transduction of AAV Vectors
por: Wang, Qizhao, et al.
Publicado: (2016)

Nanobody-Enhanced Targeting of AAV Gene Therapy Vectors
por: Eichhoff, Anna Marei, et al.
Publicado: (2019)

Exploiting microglial and peripheral immune cell crosstalk to treat Alzheimer’s disease
por: Dionisio-Santos, Dawling A., et al.
Publicado: (2019)

Efficient gene transduction in pigs and macaques with the engineered AAV vector AAV.GT5 for hemophilia B gene therapy
por: Kashiwakura, Yuji, et al.
Publicado: (2023)

Adeno-Associated Virus (AAV) as a Vector for Gene Therapy
por: Naso, Michael F., et al.
Publicado: (2017)

Brain radiation injury leads to a dose- and time-dependent recruitment of peripheral myeloid cells that depends on CCR2 signaling
por: Moravan, Michael J., et al.
Publicado: (2016)

Evaluation of AAV-DJ vector for retinal gene therapy
por: Katada, Yusaku, et al.
Publicado: (2019)

Optimized pharmacological control over the AAV-Gene-Switch vector for regulable gene therapy
por: Cheng, Shi, et al.
Publicado: (2021)

Altered dorsal CA1 neuronal population coding in the APP/PS1 mouse model of Alzheimer’s disease
por: Chockanathan, Udaysankar, et al.
Publicado: (2020)

Repopulated microglia induce expression of Cxcl13 with differential changes in Tau phosphorylation but do not impact amyloid pathology
por: Karaahmet, Berke, et al.
Publicado: (2022)

Evaluating the Effect of Interleukin-4 in the 3xTg Mouse Model of Alzheimer’s Disease
por: Dionisio-Santos, Dawling A., et al.
Publicado: (2020)

Optimized riboswitch-regulated AAV vector for VEGF-B gene therapy
por: Eriksson, Reetta A. E., et al.
Publicado: (2022)

Gene therapy following subretinal AAV5 vector delivery is not affected by a previous intravitreal AAV5 vector administration in the partner eye
por: Li, Wensheng, et al.
Publicado: (2009)

Characterization and biodistribution of under-employed gene therapy vector AAV7
por: Yost, Samantha A., et al.
Publicado: (2023)

Single-dose AAV vector gene immunotherapy to treat food allergy
por: Gonzalez-Visiedo, Miguel, et al.
Publicado: (2022)

Diagnostic accuracy and reliability of panoramic temporomandibular joint (TMJ) radiography to detect bony lesions in patients with TMJ osteoarthritis
por: Im, Yeong-Gwan, et al.
Publicado: (2018)

The Efficacy of Neck and Temporomandibular Joint (TMJ) Manual Therapy in Comparison With a Multimodal Approach in the Patients with TMJ Dysfunction: A Blinded Randomized Controlled Trial
por: Rezaie, Khaled, et al.
Publicado: (2022)

Incidental Findings in TMJ Imaging
por: Orhan, Kaan, et al.
Publicado: (2018)

Cranial irradiation mediated spine loss is sex-specific and complement receptor-3 dependent in male mice
por: Hinkle, Joshua J., et al.
Publicado: (2019)

A logistic analysis prediction model of TMJ condylar erosion in patients with TMJ arthralgia
por: Emshoff, Rüdiger, et al.
Publicado: (2021)

Developing a second-generation clinical candidate AAV vector for gene therapy of familial hypercholesterolemia
por: Wang, Lili, et al.
Publicado: (2021)

T Cell-Mediated Immune Responses to AAV and AAV Vectors
por: Ertl, Hildegund C. J.
Publicado: (2021)

A comparison of AAV-vector production methods for gene therapy and preclinical assessment
por: Davidsson, Marcus, et al.
Publicado: (2020)

The Structure of an AAV5-AAVR Complex at 2.5 Å Resolution: Implications for Cellular Entry and Immune Neutralization of AAV Gene Therapy Vectors
por: Silveria, Mark A., et al.
Publicado: (2020)

Corrigendum: Optimized riboswitch-regulated AAV vector for VEGF-B gene therapy
por: Eriksson, Reetta A. E., et al.
Publicado: (2023)

TMJ Dysfunction and Systemic Correlation
por: Fiorillo, Luca, et al.
Publicado: (2020)

AAV-8 and AAV-9 Vectors Cooperate with Serum Proteins Differently Than AAV-1 and AAV-6
por: Denard, Jérôme, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_l8g8r1i4lqckaelojh1u8nqi0h